Ally works closely with the Institute’s Executive Team to oversee strategy development and execution for technology translation in the broadly defined areas of healthcare and sustainability. She is responsible for developing Wyss internal entrepreneurs and act as central contact to industry, KOLs, and VCs. Her journey spans three continents across biomedical research, start-up, business strategy and corporate innovation in Fortune 500 life science company, and start-up advisory, including MassChallenge and MIT Hacking Medicine. She holds a PhD in biomedical sciences from the University of Auckland, New Zealand and her MBA from Cornell University.